DPP-4 inhibitor and estrogen share similar efficacy against cardiac ischemic-reperfusion injury in obese-insulin resistant and estrogen-deprived female rats

• Main Authors: Sivasinprasasn S., Tanajak P., Pongkan W., Pratchayasakul W., Chattipakorn S., Chattipakorn N.
• Format: Journal
• Published: 2017
• Online Access: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85014942592&origin=inward; http://cmuir.cmu.ac.th/jspui/handle/6653943832/40654
• Institution: Chiang Mai University

© The Author(s) 2017. Estrogen deprivation aggravates cardiac injury after myocardial ischemia and reperfusion (I/R) injury. Although either estrogen or the dipeptidyl peptidase-4 (DPP-4) inhibitor, vildagliptin, reduces myocardial damage following cardiac I/R, their effects on the heart in obese-in...